Abstract:Abstract Background To identify different network-symptom relationship may be a model of how precision medicine approach. In the July 2019 issue of AJP, Brady et al. successfully identified a network biomarker of negative symptom severity in a sample of patients with schizophrenia using resting state functional connectivity (FC) fMRI, which pushed forward the psychiatric research from purely correlational studies. As we known, medications and different episodes of the disease affect the brain function, so the breakdown of cerebellar-prefrontal network connectivity may not directly correspond to negative symptom. At this point, we would strengthen empirical support for a causal relationship between dysfunctional connectivity and psychopathology using different stages of patients with schizophrenia. Methods We used three independent cohorts with schizophrenia, one of which is 54 medication-naïve patients with first episode schizophrenia (FES) in Shanghai Mental Health Center (SH), the other is 112 medicated patients with FES in Guangzhou Huiai Hospital (GZ1), and the third is 35 chronic patients with schizophrenia in Guangzhou Huiai Hospital (GZ2). All patients were Mandarin-speaking Han Chinese and met the criteria for schizophrenia disorder based on the structured clinical interview for DSM-IV-TR. Negative symptom severity was assessed with the Scale for Assessment of Negative Symptoms (SANS) in SH cohort and with the Positive and Negative Syndrome Scale (PANSS) in GZ1 and GZ2 cohorts. MRI imaging was respectively conducted on Siemens 3.0-T (SH) and Philips 3.0-T (GZ1+GZ2) MRI systems. MRI data were preprocessed and analyzed using the DPABI toolbox, which are the same as the study of Brady et al. Furthermore, we selected the regions of interest (ROI) from the results of Brady et al. for our ROI-wise functional connectivity analysis: right dorsolateral prefrontal cortex (dlPFC, 36, 24, 30), left dorsolateral prefrontal cortex (-33, 30, 42) and midline cerebellar cortex (-9, -96, -27). Results We modeled the effect of negative symptom severity on FC between left or right dlPFC and midline cerebellar cortex while covaried the effects of head motion, age and sex. Our results showed that FC between right dlPFC and cerebellar cortex positively correlated with negative symptom severity in medication-naïve patients (SH cohort: r = 0.343, p = 0.014) and the FC tended to be significantly positively correlated with negative symptom severity in medication patients with FES (GZ1 cohort: r = 0.179, p = 0.061). However, in chronic patients with schizophrenia, the FC between right dlPFC and cerebellar cortex negatively correlated with negative symptom severity (GZ2 cohort: r = -0.390, p = 0.021). The FC between left dlPFC and cerebellar cortex did not correlate with negative symptom severity in all three cohorts. Discussion Our data of chronic patients with schizophrenia validated Brandy’s findings: negative symptom severity was found inversely correlated with FC between right dlPFC and cerebellar cortex. However, our results showed a significantly positive correlation in medication free cohort, and the significance become weaker in the medicated cohort. Our finding proved that the prefrontal cortex – cerebellum network circuit linked directly to negative symptoms, further it is a positive correlation in FES patients, and it is a negative correlation in chronic patients which are the same as Brandy’s. We speculate that medication affects function of the brain network, and then reverses the correlationship between it and the symptoms. We will follow up our two cohorts of FES patients for further fMRI data collection and symptom assessment, and test whether the network could correspond to negative symptom severity.

The neurotransmitters activities and clinical symptoms in patients with schizophrenia: a correlation analysis

Correlation between brain neurotransmitter function and clinical symptom clusters in patients with schizophrenia

Altered brain activity in the bilateral frontal cortices and neural correlation with cognitive impairment in schizophrenia

COMT, 5-HTR2A, and SLC6A4 Mrna Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association with Treatment Outcomes

A Study of Fractional Amplitude of Low Frequency Fluctuation in Schizophrenia Patients with Persistent Verbal Auditory Hallucinations

Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a <SUP>1</SUP>H MRS study

Comparative Study of Brain Function Tests Between Patients with Schizophrenia and Normal Controls

Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a 1 H MRS study

Correlation study of brain-derived neurotrophic factor, EEG γ activity and cognitive function in first-episode schizophrenia

Abnormal Concentration of GABA and Glutamate in the Prefrontal Cortex in Schizophrenia.-An in Vivo 1H-MRS Study.

Abnormal Entropy Modulation of the EEG Signal in Patients With Schizophrenia During the Auditory Paired-Stimulus Paradigm

Spatiotemporal Dynamics of Functional Connectivity and Association with Molecular Architecture in Schizophrenia.

Comparison of the Density of Gamma-Aminobutyric Acid in the Ventromedial Prefrontal Cortex of Patients with First-Episode Psychosis and Healthy Controls.

Network Analysis of Magnetoencephalogram Signals in Schizophrenia Patients When Viewing Emotional Facial Stimuli

Comparison of the density ofgamma-aminobutyric acid in the ventromedial prefrontal cortex of paitents with ifrst-episode psychosis and healthy controls

Correlations Of Encephalic Neurotransmitters With Contingent Negative Variation (Cnv) In Post-Stroke Depression Patients

Association Of Cerebral Deficits With Clinical Symptoms In Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry And Resting State Functional Connectivity Study

T144. CORRELATION BETWEEN CEREBELLAR-PREFRONTAL NETWORK CONNECTIVITY AND NEGATIVE SYMPTOMS ASSOCIATED WITH THE STAGES OF SCHIZOPHRENIA

Correlations between omega-3 fatty acids and inflammatory/glial abnormalities: the involvement of the membrane and neurotransmitter dysfunction in schizophrenia

[Association Analysis Between Dopamine D1 Receptor Gene and Symptom Quantitative Trait of Schizophrenia].

Correlation of abnormalities in resting state fMRI with executive functioning in chronic schizophrenia